H2APEX Group SCA (H2A) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of H2APEX Group SCA €0.30, price €1.02, upside -70.8%, quality 12 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch H2APEX Group SCA for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range €0.7340 – €7.05 · fair‑value band €0.2210 – €0.4420 · the €1.02 price screens above the €0.2975 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow H2APEX Group SCA in your weekly email
Every Wednesday you see whether H2APEX Group SCA is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
H2APEX Group SCA develops, manufactures, and operates green hydrogen plants for the de-carbonization of industry and infrastructure in Germany and Luxembourg. It operates through Operations, Project Development, and Storage segments.
Show more
H2APEX Group SCA develops, manufactures, and operates green hydrogen plants for the de-carbonization of industry and infrastructure in Germany and Luxembourg. It operates through Operations, Project Development, and Storage segments. The Operations segment includes production and selling of green hydrogen, as well as the derivatives electricity and heat generation. The Project Development segment comprises work related to project development and system integration for third-party hydrogen plants, as well as turnkey solutions for the supply of hydrogen are modular, tech-agnostic, and tailor-made. The Storage segment includes development and manufacturing of different hydrogen storage systems. It serves transportation and logistics, industry, engineering office, research, government, and automobile manufacturer sectors. H2APEX Group SCA was founded in 2000 and is headquartered in Rostock, Germany.
Stock analysis
H2APEX Group SCA (H2A) currently trades at €1.02, while our model-based Fair Value estimate is €0.2975, implying the stock looks roughly 242.8% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 94/100, which puts the evidence level at low.
Scenario range: €0.2210 (bear) to €0.4420 (bull), the price of €1.02 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 12/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
H2APEX Group SCA reported revenue of €10.0M in FY2025 versus €1.3M in FY2021, a compound +67.0%/yr. Reported net income was −€33.8M in FY2025.
Key figures
Market cap €51.2M · P/S ratio 2.60 · EPS (TTM) €−0.7400 · Net margin −220% · Return on equity −164% · Return on assets (EBIT) −18.6% · Operating margin −221% · Revenue (TTM) €15.4M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 58% below its 52-week high and 39% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at −71%, H2A screens richer than that median.
Fair Value models
Bear €0.2210Fair Value €0.2975Bull €0.4420
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−66.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+37.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−26.2%
Start year 2020 (pandemic). Over 10 years: −25.2% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−18.4%
’13
’14
’15
’16
’17
’18
’19
’20
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−3.8% (2020) → −352.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 714 stocks
Beats the industry median on 1/7 measures
Overall it trails its industry peers.
Valuation
Quality Score15 · Bottom 25%
Fair Value upside−71% · Bottom 25%
Profitability
Return on assets−25% · Bottom 25%
Growth and dividend
Revenue growth70% · Top 25%
Balance sheet
Debt / equity1.32× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/B2.18× · Pricier than median
P/S (TTM)3.78× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 21
PAST (return on equity)0· sector 23
HEALTH (low debt)34· sector 95
DIVIDEND (yield)0· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "H2APEX Group SCA Fair Value". https://www.fairvalue-calculator.com/stock/H2A
Frequently asked questions
Is H2APEX Group SCA (H2A) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of €0.2975 versus a price of €1.02, about −71% upside (overvalued).
What is the fair value of H2A?
Our model-based fair value for H2APEX Group SCA is €0.2975 (as of Sep 23, 2026), built from audited fundamentals. The current price: €1.02.
What is the quality score of H2A?
H2APEX Group SCA has a Quality Score of 12/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for H2APEX Group SCA (H2A)?
Our model-based price target is the fair value of €0.2975 (as of Sep 23, 2026) from 1 valuation models. Cautious scenario €0.2210, optimistic scenario €0.4420. It is a calculation from audited fundamentals, not an analyst target.
What is the H2APEX Group SCA stock forecast for 2026?
Our models put fair value at €0.2975, about −71% upside versus a price of €1.02 (overvalued). Cautious scenario €0.2210, optimistic scenario €0.4420. The calculation is refreshed regularly with new filings.
What is the revenue of H2APEX Group SCA (H2A)?
H2APEX Group SCA reported trailing-twelve-month revenue of about €15.4M (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of H2APEX Group SCA (H2A)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For H2APEX Group SCA it is €0.2975 per share (as of Sep 23, 2026), against a price of €1.02. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is H2APEX Group SCA stock overvalued or undervalued in 2026?
As of Sep 23, 2026, H2A trades above its calculated fair value: price €1.02, fair value €0.2975, a gap of about −71% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of H2A?
No. The price is what the market pays today (€1.02); the fair value is what the company's own numbers justify (€0.2975). For H2APEX Group SCA the two are €0.7225 per share apart. That gap is exactly why we show both numbers side by side.
How much is H2APEX Group SCA worth?
The market values H2APEX Group SCA at about €51.2M (market capitalisation, as of Sep 23, 2026). Per share that is €1.02; our models calculate a fair value of €0.2975 per share.
What do the bullish and bearish scenarios say about H2A?
Our models span a range for H2APEX Group SCA: cautious scenario €0.2210, base €0.2975, optimistic €0.4420 per share (as of Sep 23, 2026, price €1.02). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of H2APEX Group SCA (H2A)?
Balance-sheet figures for H2APEX Group SCA (as of Sep 23, 2026): return on equity −163.8%, debt of 1.32 per unit of equity. They feed the Quality Score of 12/100, which measures business quality independently of the share price.
How far is H2A from its 52-week high?
H2APEX Group SCA trades at €1.02, about 58% below its 52-week high of €2.44 and 39% above the low of €0.7340 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of €0.2975 is for.
Which stocks are comparable to H2APEX Group SCA?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is H2APEX Group SCA stock attractive at the current price?
The data as of Sep 23, 2026: price €1.02, calculated fair value €0.2975 (−71%), Quality Score 12/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of H2A calculated?
We run H2APEX Group SCA through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €0.2975, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. H2APEX Group SCA itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of H2APEX Group SCA (H2A)?
The closing price on Sep 23, 2026 was €1.02. Our model-based fair value is €0.2975, about −71% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with H2APEX Group SCA right now?
The price sits above even our optimistic bull case (€0.4420). The favourable scenario is already priced in. Weak quality (12/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (€0.2210 to €0.4420) leaves room in how you read the outcome.
Key figures of H2APEX Group SCA
How large is the market capitalisation of H2APEX Group SCA (H2A)?
The market capitalisation of H2APEX Group SCA is €51.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of H2APEX Group SCA (H2A)?
The price-to-sales ratio of H2APEX Group SCA is 2.60 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of H2APEX Group SCA (H2A)?
Earnings per share at H2APEX Group SCA are €−0.7400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of H2APEX Group SCA (H2A)?
The net margin of H2APEX Group SCA is −220% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of H2APEX Group SCA (H2A)?
The return on equity (ROE) of H2APEX Group SCA is −164% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of H2APEX Group SCA (H2A)?
On an EBIT basis the return on assets of H2APEX Group SCA is −18.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of H2APEX Group SCA (H2A)?
The operating margin of H2APEX Group SCA is −221% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at H2APEX Group SCA (H2A)?
Revenue at H2APEX Group SCA is growing +70.4% versus a year earlier (3y avg +37.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does H2APEX Group SCA (H2A) generate?
The free cash flow of H2APEX Group SCA is −€47.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does H2APEX Group SCA (H2A) carry?
The net debt of H2APEX Group SCA is €33.5M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch H2APEX Group SCA in the live analysis
One click puts H2APEX Group SCA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
